Abstract
Diet and poor eating habits continue to play a significant role in the health of individuals. Improvements in public health, low-cost food production, transportation, and food processing have eliminated most nutrient deficiencies in this country and replaced them with diseases of excess calories. The Surgeon General’s Report on Nutrition and Health (1988) ranked the 10 leading causes of death in the United States (1). Several were strongly related to dietary excess, including coronary heart disease (CHD), cancer, stroke, diabetes mellitus, and atherosclerosis. Despite the recommendations in the Surgeon General’s Report (1) to maintain a desirable weight and a caloric intake pattern in keeping with energy expenditure, Americans have experienced a substantial increase in body wt and obesity related morbidity and mortality. In fact, the prevalence of overweight and obesity is currently estimated at 54% of the adult population (2). The greatest increase is in those classified as obese and morbidly obese. These are represented by the heaviest individuals (now estimated at 22%) with a body mass index (BMI) of >30 and >40 kg/m2, respectively (3; Fig. 1). Of greatest concern is the increased incidence of obesity in children. Evidence suggests that they will be the next generation of obese adults, with the accompanying disease risks. This incidence is currently estimated at 14%, using the 95th percentile of weight (4; Fig. 2).
“Opinion is a flitting thing but truth outlasts the sun”
—Emily Dickinson
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
The Surgeon General’ s Report on Nutrition and Health. DHHS (PHS) Publ No. 88-50210 Washington DC, 1988.
National Heart, Lung, and Blood Institute. NIH. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Obes Res 1998; 6: 51S - 1805.
Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes 1998; 22: 39 - 47.
Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends for children and adolescents. Arch Pediatr Adolesc Med 1995; 149: 1085 - 1091.
Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 1998; 6: 97 - 106.
Bender R, Jöckel K-H, Trautner C, Spraul M, Berger M. Effect of age on excess mortality in obesity. JAMA 1999; 281: 1498 - 1504.
Williamson DF, Pamuk ER. The association between weight loss and increased longevity. Ann Intern Med 1993; 119: 732 - 736.
Andres R, Muller DC, Sorkin JD. Long-term effects of change in body weight on all-cause mortality. Ann Intern Med 1993; 119: 737 - 743.
Williamson DF. “Weight cycling” and mortality: how do the epidemiologists explain the role of intentional weight loss. J Am Coll Nutr 1996; 15:6-13.
Lean MEJ, Powrie JK, Anderson AS, Garthwaite PH. Obesity, weight loss and prognosis in type 2 diabetes. Diabetic Med 1990; 7: 228 - 233.
Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes 1992; 16: 397 - 415.
Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol 1995; 141: 1128 - 1141.
Blake GH. Control of type II diabetes: reaping the rewards of exercise and weight loss. PostGrad Med 1992; 92: 129 - 137.
Ohlson L, Larrson B, Eriksson H, Svärdsudd K, Welin L, Tibblin G. Diabetes mellitus in Swedish middle-aged men: the study of men born in 1913 and 1923. Diabetologia 1987; 30: 386 - 393.
Pi-Sunyer FX. Short-term medical benefits and adverse effects of weight loss. Am Coll Phys 1993; 119: 722 - 726.
Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 21: 785 - 789.
Campbell PJ, Gerich JE. Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity. J Clin Endocrinol Metab 1990; 70: 1114 - 1118.
Campbell PJ, Carlson MG. Impact of obesity on insulin action in NIDDM. Diabetes 1993; 42: 405 - 410.
Lundgren H, Bengtsson C, Blohme G, Lapidus L, Sjöström L. Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenberg, Sweden. Int J Obes 1987; 13: 413 - 423.
Ohlson L-O, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Björntorp P, Tibblin G. The influence of body fat distribution on the incidence of diabetes mellitus. Diabetes 1985; 34: 1055 - 1058.
Cassano PA, Rosner B, Vokonas PS, Weiss ST. Obesity and body fat distribution in relation to the incidence of non-insulin-dependent diabetes mellitus. Am J Epidemiol 1992; 136: 1474 - 1486.
Syvänne M, Taskinen M-R. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 1997; 350: 20 - 23.
Nathan DM, Meigs J, Singer DE. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is...or is it? Lancet 1997; 350: 4 - 9.
Wing RR, Blair EH, Bononi P, Marcus MD, Watanabe R, Bergman RN. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 1994; 17: 30 - 36.
Pories WJ, Swanson MS, MacDonald MD, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339 - 352.
Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC. Association of HbAlc with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992; 41: 202 - 208.
Meigs JB, Singer DE, Nathan DM, Cupples LA, Wilson PWF. Metabolic abnormalities associated with glucose intolerance extend across the spectrum of prevalent glucose tolerance in 3297 Framingham offspring study subjects. Diabetes 1995; 44: 5A.
Bosello O, Armellini F, Zamboni M, Fitchet M. The benefits of modest weight loss in type II diabetes. Int J Obes 1997; 21: S10 - S13.
Weinsier RL, James D, Darnell BE, Wooldrigde NH, Birch R, Hunter GR, Bartolucci AA. Lipid and insulin concentrations in obese postmenopausal women: separate effects of energy restriction and weight loss. Am J Clin Nutr 1992; 56: 44 - 49.
Inoue S, Okamura A, Okamoto M, Tanaka K, Sugimasa T, Takamura Y. Effects of very low calorie diet (VLCD) on body weight, blood glucose and serum lipid metabolism in severe obesity with glucose intolerance. Int J Obes 1989; 13: 183 - 184.
Wing RR, Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EH. Effects of a very-lowcalorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med 1991; 151: 1334 - 1340.
Uusitupa M, Laakso M, Sarlund H, Majander H, Takala J, Penttilä I. Effects of a very-low-calorie diet on metabolic control and cardiovascular risk factors in the treatment of obese non-insulin-dependent diabetics. Am J Clin Nutr 1990; 51: 768 - 773.
Joint National Committee. The 1984 report of the Joint National Committee on the detection, evaluation, and treatment of high blood pressure. Arch Int Med 1984; 144: 1045 - 1057.
Frolich ED. Mechanisms contributing to high blood pressure. Ann Int Med 1983; 98: 709 - 714.
Bray GA. Obesity. In: Present Knowledge in Nutrition. Ziegler EE, Filer LJ, eds. Washington DC: ILSI Press, 1996; 19 - 32.
Hypertension Detection and Follow-Up Program Cooperative Group. Race education and prevalence of hypertension. Am J Epidemiol 1977; 106: 351 - 361.
Havlik RJ, Hubert HB, Fabsitz RR, Feinleib M. Weight and hypertension. Ann Intern Med 1983; 98: 855 - 859.
Stamler J, Caggiula AW, Grandits GA. Relation of body mass and alcohol, nutrient, fiber and caffeine intakes to blood pressure in the special intervention and usual care groups in the multiple risk factor intervention trial. Am J Clin Nutr 1997; 65: 338S - 365S.
Björntorp P. Obesity. Lancet 1997; 350: 423 - 426.
Reisin E, Frohlich ED, Messerli FH, Dreslinski GR, Dunn FG, Jones MM, Batson HM. Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med 1983; 98: 315 - 319.
MacMahon S, Cutler J, Brittain E, Higgins M. Obesity and hypertension: epidemiological and clinical issues. Eur Heart J 1987; 8: 57 - 70.
Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly. JAMA 1998; 279: 839 - 846.
Whelton PK, Kumanyika SK, Cook NR, Cutler JA, Borhani NO, Hennekens CH, et al. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Am J Clin Nutr 1997; 65: 652S - 660S.
Cook NR, Jerome C, Hebert PR, Taylor JO, Hennekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 1995; 155: 701 - 709.
Johnson CL, Rifkind BM, Sempos CT, Carroll MD, Bachorik PS, Briefel RR, et al. Declining serum total cholesterol levels among US adults. JAMA 1993; 269: 3002 - 3008.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Pressure in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II) JAMA 1993; 269: 3015 - 3023.
Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992; 86: 1046 - 1060.
Hulley SB, Walsh JMB, Newman TB. Health policy on blood cholesterol: time to change directions. Circulation 1992; 86: 1026 - 1029.
Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, Willett WC, Manson JE. Abdominal adiposity and coronary heart disease in women. JAMA 1998; 280: 1843 - 1848.
Rexrode KM, Hennekens CH, Willett WC, Colditz GA, Stampfer MJ, Rich-Edwards JW, Speizer FE, Manson JE. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997; 277: 1539 - 1545.
Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, Hennekens CH. Weight, weight change, and coronary heart disease in women. JAMA 1995; 273: 461 - 464.
Denke MA, Sempos CT, Grundy SM. Excess body weight: an under-recognized contributor to dyslipidemia in white American women. Arch Intern Med 1994; 154: 401 - 410.
Denke MA, Sempos CT, Grundy SM. Excess body weight: an under-recognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 1993; 153: 1093 - 1103.
Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, Speizer FE, Henneken CH. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322: 882 - 889.
Higgins M, Kannel W, Garrison R, Pinsky J, Stokes J III. Hazards of obesity: the Framingham experience. Acta Med Scand 1988; 723: 23 - 36.
Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968 - 976.
Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 1984; 289: 1257 - 1261.
Larsson B, Svärdsudd K, Welin L, Wilhlemsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J 1984; 288: 1401 - 1404.
Donahue RP, Bloom E, Yano K, Abbott RD, Reed DM. Central obesity and coronary heart disease in men. Lancet 1987; 2: 821 - 824.
Van Gaal LF, Wauters MA, De Leeuw IH. The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes 1997; 21: S5 - S9.
Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson JD, Mellows S, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park heart study. Lancet 1986; 2: 533 - 537.
Landin K, Stigendal L, Eridsson E, Krotkiewski M, Risberg B, Tengborn L, Smith U. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990; 39: 1044 - 1048.
Nixon DW, Rodgers K. Breast cancer. In: Nutritional Oncology. Heber D, Blackburn GL, Go VLW, eds. New York: Academic, 1999; 447 - 451.
Hunter DJ, Willett WC. Diet, body build, and breast cancer. Ann Rev Nutr 1994; 14: 393 - 418.
Ballard-Barbash R. Energy balance, anthropometry, and cancer. In: Nutritional Oncology. Heber D, Blackburn GL, Go VLW, eds. New York: Academic, 1999; 137 - 151.
Holmes MD, Hunter DJ, Colditz GA, Stampfer MJ, Hankinson SE, Speizer FE, Rosner B, Willett WC. Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA 1999; 281: 914 - 920.
Bjöntorp P. The associations between obesity, adipose tissue distribution and disease. Acta Med Scand 1988; 723: 121 - 134.
Heber D, Blackburn G, Go VLW. Introduction: the principles of nutritional oncology. In: Nutritional Oncology. Heber D, Blackburn GL, Go VLW, eds. New York: Academic, 1999; 1 - 4.
Willett WC. Specific fatty acids and risks of breast and prostate cancer: dietary intake. Am J Clin Nutr 1997; 66: 1557S - 1563S.
Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, et al. Can lifestyle changes reverse coronary heart disease? Lancet 1990; 336: 129 - 133.
Ornish D, Scherwitz LW, Billings JH, Gould KL, Merritt TA, Sparler S, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998; 280: 2001 - 2007.
McCarron DA, Oparil S, Chait A, Haynes B, Kris-Etherton P, Stern JS, et al. Nutritional management of cardiovascular risk factors. Arch Intern Med 1997; 157: 169 - 177.
Singh RB, Rastogi SS, Verma R, Laxmi B, Singh R, Ghosh S, Niaz MA. Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. Br Med J 1992; 304: 1015 - 1019.
Ditschuneit HH, Flechtner-Mors M, Johnson TD, Adler G. Metabolic and weight-loss effects of a longterm dietary intervention in obese patients. Am J Clin Nutr 1999; 69: 198 - 204.
Ditschuneit HH, Flechtner-Mors M, Johnson TD, et al. Metabolic and weight loss effects of long-term dietary intervention in obese patients. Obes Res 2000; 8 (5): 399 - 402.
Kassirer JP, Angell M. Losing weight-an ill fated New Year’s resolution. N Engl J Med 1998; 338: 52 - 54.
Yusuf S, Wittes J, Friedman L. Overview of the results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988; 260: 2259 - 2263.
Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. Br Med J 1990; 301: 309 - 314.
Scandinavian Simvastin Survival Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastin Survival Study (4S). Lancet 1994; 344: 1383 - 1389.
Willett WC, Dietz WH, Coditz GA. Guidelines for healthy weight. N Engl J Med 1999; 341: 427 - 434.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Frier, H.I., Greene, H.L. (2001). Obesity and Chronic Disease. In: Bendich, A., Deckelbaum, R.J. (eds) Primary and Secondary Preventive Nutrition. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-039-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-59259-039-1_12
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-173-8
Online ISBN: 978-1-59259-039-1
eBook Packages: Springer Book Archive